Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Top Life Sciences Consultancies in the USA: What Sets EvoLV Apart

Sep 28, 2025

Introduction to Life Sciences Consultancies

Life sciences consultancies play a crucial role in advancing the healthcare industry by providing expert guidance and strategic solutions. These firms assist in navigating regulatory landscapes, optimizing operational efficiencies, and fostering innovation in pharmaceuticals, biotechnology, and medical devices. Among the numerous consultancies operating in the USA, EvoLV stands out for its unique approach and impactful services.

life sciences consulting

Comprehensive Expertise and Services

EvoLV distinguishes itself through a broad spectrum of services tailored to meet the diverse needs of its clients. The consultancy offers expertise in areas such as regulatory compliance, market access, clinical development, and digital transformation. By leveraging a team of seasoned professionals, EvoLV ensures that clients receive informed, strategic advice that is crucial for their growth and success in the competitive life sciences sector.

One of the key aspects of EvoLV's service offering is its ability to integrate cutting-edge technology with traditional consulting practices. This blend allows for dynamic solutions that are both innovative and practical, helping clients stay ahead of industry trends and regulatory changes.

Client-Centric Approach

What truly sets EvoLV apart is its unwavering commitment to a client-centric approach. The consultancy prioritizes understanding each client's unique challenges and objectives, ensuring that solutions are customized to deliver maximum impact. This personalized attention fosters strong partnerships and leads to long-lasting results.

consulting team

EvoLV's client-centric model also emphasizes transparency and communication. Clients are kept informed at every stage of the consulting process, allowing for collaborative decision-making and ensuring that all stakeholders are aligned on strategic goals.

Innovation and Forward-Thinking Strategies

Innovation is at the heart of EvoLV's ethos. The firm consistently invests in research and development to stay at the forefront of technological advancements in the life sciences field. This dedication to innovation enables EvoLV to offer solutions that are not only effective but also future-proof, helping clients navigate an ever-evolving landscape.

Furthermore, EvoLV's forward-thinking strategies are designed to anticipate industry shifts and prepare clients for emerging opportunities. By staying ahead of the curve, EvoLV ensures that its clients are well-positioned to capitalize on new trends and technologies.

innovation

Proven Track Record of Success

EvoLV's success stories speak for themselves. With a proven track record of delivering tangible results, the consultancy has earned a reputation for excellence in the life sciences sector. Clients frequently report significant improvements in operational efficiency, accelerated time-to-market, and enhanced competitive positioning as a result of working with EvoLV.

The consultancy's ability to deliver consistent value is further evidenced by a high rate of client retention and repeat business. This ongoing trust underscores EvoLV's status as a leader in life sciences consulting.

Conclusion: The EvoLV Advantage

In conclusion, EvoLV exemplifies what it means to be a top-tier life sciences consultancy in the USA. Through its comprehensive expertise, client-centric approach, commitment to innovation, and proven success record, EvoLV offers unparalleled value to its clients. For organizations seeking strategic guidance in the life sciences sector, EvoLV represents a partner that is not only knowledgeable but also deeply invested in their success.